Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Elife ; 72018 03 07.
Article in English | MEDLINE | ID: mdl-29513221

ABSTRACT

Intermediate filaments (IF) are a major component of the metazoan cytoskeleton and are essential for normal cell morphology, motility, and signal transduction. Dysregulation of IFs causes a wide range of human diseases, including skin disorders, cardiomyopathies, lipodystrophy, and neuropathy. Despite this pathophysiological significance, how cells regulate IF structure, dynamics, and function remains poorly understood. Here, we show that site-specific modification of the prototypical IF protein vimentin with O-linked ß-N-acetylglucosamine (O-GlcNAc) mediates its homotypic protein-protein interactions and is required in human cells for IF morphology and cell migration. In addition, we show that the intracellular pathogen Chlamydia trachomatis, which remodels the host IF cytoskeleton during infection, requires specific vimentin glycosylation sites and O-GlcNAc transferase activity to maintain its replicative niche. Our results provide new insight into the biochemical and cell biological functions of vimentin O-GlcNAcylation, and may have broad implications for our understanding of the regulation of IF proteins in general.


Subject(s)
Acetylglucosamine/genetics , Cell Movement/genetics , Cytoskeleton/genetics , Intermediate Filaments/genetics , Acetylglucosamine/metabolism , Animals , Glycosylation , Humans , N-Acetylglucosaminyltransferases/genetics , Phosphorylation , Protein Processing, Post-Translational/genetics , Signal Transduction , Vimentin/genetics
2.
Biochemistry ; 57(1): 13-21, 2018 01 09.
Article in English | MEDLINE | ID: mdl-29099585

ABSTRACT

O-Linked ß-N-acetylglucosamine (O-GlcNAc) is a critical post-translational modification (PTM) of thousands of intracellular proteins. Reversible O-GlcNAcylation governs many aspects of cell physiology and is dysregulated in numerous human diseases. Despite this broad pathophysiological significance, major aspects of O-GlcNAc signaling remain poorly understood, including the biochemical mechanisms through which O-GlcNAc transduces information. Recent work from many laboratories, including our own, has revealed that O-GlcNAc, like other intracellular PTMs, can control its substrates' functions by inhibiting or inducing protein-protein interactions. This dynamic regulation of multiprotein complexes exerts diverse downstream signaling effects in a range of processes, cell types, and organisms. Here, we review the literature about O-GlcNAc-regulated protein-protein interactions and suggest important questions for future studies in the field.


Subject(s)
Acetylglucosamine/metabolism , Biochemistry/methods , Models, Biological , Protein Processing, Post-Translational , Signal Transduction , Acetylglucosamine/chemistry , Aminoacylation , Animals , Biochemistry/trends , Humans , Protein Interaction Domains and Motifs , Protein Multimerization
SELECTION OF CITATIONS
SEARCH DETAIL
...